(Q43771902)

26 November 2017

title

Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation (English)

1 reference

26 November 2017

1 reference

V Venard

1

1 reference

26 November 2017

J N Dauendorffer

2

1 reference

26 November 2017

A S Carret

3

1 reference

26 November 2017

D Corsaro

4

1 reference

26 November 2017

D Edert

5

1 reference

26 November 2017

P Bordigoni

6

1 reference

26 November 2017

A Le Faou

7

1 reference

26 November 2017

publication date

1 September 2001

1 reference

26 November 2017

published in

Pathology and Biology

1 reference

26 November 2017

volume

49

1 reference

26 November 2017

issue

7

1 reference

26 November 2017

page(s)

553-558

1 reference

Recurrent Infection with Herpes Simplex Virus after Marrow Transplantation: Role of the Specific Immune Response and Acyclovir Treatment

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Acyclovir prophylaxis of herpes-simplex-virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Susceptibility of clinical strains of herpes simplex virus to three nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Occurrence and characterization of acyclovir‐resistant herpes simplex virus isolates: Report on a two—year sensitivity screening survey

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Herpesviral thymidine kinases: laxity and resistance by design

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

New therapeutic approaches to the alphaherpesvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2801%2900205-X

7 January 2021

10.1016/S0369-8114(01)00205-X

Identifiers

DOI

1 reference

26 November 2017

1 reference